Todos Medical (OTCQB:TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, announced today that the U.S. Patent and Trademark Office has granted to Todos Medical two patents for broader claims for its inventions.
As quoted in the press release:
The first patent is titled, Biochemical Analysis of PBMCs (US 9,606,057 B2). The patent relates to analysis of an infrared spectrum of a peripheral blood mononuclear cells sample to indicate the presence of a solid tumor in breast tissue.
The second patent is titled, Infrared Analysis of Benign Tumors (US 9,804,145 B2). The patent covers Todos Medical’s innovative TBIA technology applied to differentiate between benign and malignant tumors.